- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/54 - Sulfur atoms
Patent holdings for IPC class C07D 211/54
Total number of patents in this class: 133
10-year publication summary
|
10
|
13
|
8
|
10
|
11
|
10
|
9
|
14
|
12
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4093 |
9 |
| Hoffmann-La Roche Inc. | 3454 |
7 |
| F. Hoffmann-La Roche AG | 7939 |
5 |
| Inflazome Limited | 85 |
5 |
| 89bio Ltd | 19 |
5 |
| Canopy Growth Corporation | 221 |
4 |
| Enanta Pharmaceuticals, Inc. | 428 |
4 |
| Bristol-myers Squibb Company | 4872 |
3 |
| Horizon Orphan LLC. | 35 |
3 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 264 |
3 |
| Samsung Display Co., Ltd. | 35017 |
2 |
| The Regents of the University of California | 20015 |
2 |
| Genentech, Inc. | 3979 |
2 |
| Boehringer Ingelheim International GmbH | 4645 |
2 |
| Merck Patent GmbH | 5814 |
2 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 286 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 763 |
2 |
| Idemitsu Kosan Co., Ltd. | 4228 |
2 |
| Henkel AG & Co. KGaA | 10590 |
2 |
| Neuropore Therapies, Inc. | 38 |
2 |
| Other owners | 65 |